Learn more about our upcoming Galas and Signature Events Learn More
DENVER, CO – The Melanoma Research Foundation (MRF) will host its 14th Annual Denver Gala on Thursday, September 18 at its new venue, Asterisk Denver. This year’s event...
Michael Heiferman’s Abstract Uveal Melanoma (UM), a deadly cancer arising in the eye, is the most common eye cancer in adults. Early detection of UM is important due ...
Kazuko Nishikura’s Abstract The phenomenon of “RNA editing” is a relatively recent discovery with exciting implications. RNA editing is a process that modifies th...
Korbinian Kropp’s Abstract A major reason that T cell-based melanoma immunotherapies can fail, either initially or after a period of treatment, is due to mutations th...
Sarwish Rafiq’s Abstract Metastatic melanoma is one of the most aggressive, and complex cancers with a 35% 5-year survival rate. Therapies using T cells that are gene...
Prashanthi Dharanipragada’s Abstract For decades, cancer initiation and progression are thought to occur gradually through small mutational changes in its DNA. After ...
Devarati Mitra’s Abstract Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactor...
SMR Young Investigator Award – Vito Rebecca, PhD
Vito Rebecca’s Abstract Melanoma is the most aggressive form of skin cancer. Although progress has been made for advanced melanoma patients with 13 new FDA-approved t...
Sep 25, 2025 ET
